FDA clears chemical countermeasure
This article was originally published in The Gray Sheet
Executive Summary
Canada-based O'Dell Engineering is in the process of securing a contract with the U.S. military for the firm's RSDL (Reactive Skin Decontamination Lotion), following FDA clearance March 26 based on a 300-patient trial co-sponsored by the U.S. Marine Corps. RSDL - a sponge impregnated with lotion that "if used in time...can prevent the serious burns and deaths that result from exposure to chemical warfare agents," according to FDA Commissioner Mark McClellan - will be marketed for use by the military and journalists at risk for exposure to chemical weapons. FDA granted RSDL expedited review in January, but had delayed clearance to request further information...